CRDL
Cardiol Therapeutics
CRDL
CRDL
33 hedge funds and large institutions have $5.97M invested in Cardiol Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
33
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$89K | |
| 2 | +$50.2K | |
| 3 | +$35.6K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$27.2K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$26.7K |
Top Sellers
| 1 | -$382K | |
| 2 | -$178K | |
| 3 | -$62.2K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$29.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$16.1K |